Effects of Adjuvant Medications on A1C, Body Mass Index, and Insulin Requirements among Patients with Type 1 Diabetes

Randomized controlled trials have demonstrated that noninsulin medications used to treat type 2 diabetes can improve health outcomes among patients with type 1 diabetes (T1D). This study assessed the effects of adjuvant diabetes medications on glycated hemoglobin (A1C), body mass index (BMI), or tot...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva Almodóvar, Armando, Clevenger, Jonathan, Nahata, Milap C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412392/
https://www.ncbi.nlm.nih.gov/pubmed/36005937
http://dx.doi.org/10.3390/pharmacy10040097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412392/
https://www.ncbi.nlm.nih.gov/pubmed/36005937
http://dx.doi.org/10.3390/pharmacy10040097

Ejemplares similares